Page 3

Zipnosis sees Bright future in acquisition deal
Fairview Health Services and Ascension Ventures have exited the telehealth software provider, which has been bought by Bright Health Group.
Brattea rattles off series B-plus round
The renal denervation product developer secured more than $20m in a round that included strategic investor BrosMed Medical.
PharmEasy fits Prosus into $350m round
The online pharmacy is set to close a round co-led by Prosus Ventures at a $1.5bn post-money valuation, taking its overall funding past $670m.
SoftBank heads to $150m round for Edda
Surgical imaging system developer Edda Technology has raised $150m in a round led by SoftBank Vision Fund 2.
Inscripta tips in $150m
The Institut Mérieux-backed genome engineering platform developer has closed its series E round with commitments from new and existing investors.
Ikena closes initial public offering
The Bristol Myers Squibb-backed oncology drug developer ultimately raised nearly $144m in its initial public offering.
Allm calls in $50m in series A
Capital Medica, Cyberdyne, Eisai, Financial Agency, Mitsui, Mixi, Opt, NID, Philips, Sompo and Vector all took part in a round for the medical ICT tool developer.
Impel NeuroPharma files for $75m IPO
The central nervous system-focused drug developer has raised approximately $124m so far from investors including 3M.
Alloy Therapeutics amalgamates $75m
Alexandria Real Estate Equities was among the participants as the drug discovery technology provider closed its series C round.
Corporate venturing deal net: 29 March-1 April 2021
Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

test reg